期刊文献+

L-硝基-精氨酸甲酯对大鼠脑缺血再灌注损伤后血脑屏障功能和基质金属蛋白酶-9表达的影响 被引量:2

Effects of L-NAME on blood-brain barrier permeability and MMP-9 expression after cerebral ischemia and reperfusion injury in rats
暂未订购
导出
摘要 目的:观察L-硝基-精氨酸甲酯(L-NAME)对大鼠脑缺血再灌注损伤后血脑屏障功能和MMP-9表达的影响,探讨其对脑缺血再灌注损伤的保护作用及其机制。方法:将60只SD大鼠随机分为3组:1假手术组;2对照组;3L-NAME治疗组。用线栓法制作大鼠脑缺血再灌注模型,再灌注48h后干湿重法测定缺血脑组织含水量,用伊文思蓝测定血脑屏障通透性,免疫组织化学技术检测MMP-9的表达,同时电镜观察血脑屏障的变化。结果:脑缺血再灌注48h,对照组缺血侧脑含水量明显升高,EB含量也明显增加,电镜观察发现血脑屏障破坏严重,MMP-9的表达也较假手术组显著增加;而应用L-NAME处理的大鼠其缺血脑组织含水量明显减少,缺血侧EB含量较对照组也明显降低(P<0.05),同时电镜观察到血脑屏障的破坏减轻,而MMP-9表达水平也明显低于对照组。结论:L-NAME对大鼠脑缺血再灌注损伤后的血脑屏障具有保护作用,其作用机制可能是通过抑制MMP-9表达来实现的。 Objective: To investigate the effects of L-NAME on blood-brain barrier of cerebral ischemia and reperfusion in rats,and explore the possible mechanisms. Methods: 60 normal male SD rats were divided randomly into 3 groups:(1)Sham-operation (n = 20); (2)Control (n= 20);(3)L-NAME (n = 20). Rat cerebral ischemia and reperfusion model was established by the method of thread inserting right middle cerebral artery occlusion(MCAO), The brain water content was measured 48 h after reperfusion. At the same time,The permeability of blood-brain barrier was observed with electron microscope and by detecting the content of Evans Blue leaked out the brain tissue of ischemic side. The expression of MMP-9 in different groups was dtected by immunohistochemical method. Results: 48 h after crebral ischemia and reperfusion injuriy, the content of brain water and Evans Blue leaked out increased obviously, The breakdown of blood-brain barrier was severe the expression of MMP-9 also increased obviously. However, L-NAME can subtract the content of brain edema and Evans blue(P〈0.05), relieve the breakdowm of blood-brain barrier on electron microscope. The expression of MMP-9 were decreased in L-NAME group contrasted with control group(P〈0.05). Conclution: L-NAME has the protective effects on BBB in the model of cerebral ischemia and reperfusion injury. The mechanisms may be by restrainning the expression of MMP-9.
出处 《陕西医学杂志》 CAS 2009年第5期537-540,共4页 Shaanxi Medical Journal
关键词 脑缺血/药物疗法 再灌注损伤/药物疗法 血脑屏障 明胶酶B/代谢 模型 大鼠 Brain ischemia/drug therapy Reperfusion injury/drug therapy Blood-brain barrier Gelatinase B/metabolism Model , animals Rats
  • 相关文献

参考文献14

  • 1Dijkhuizen RM,Asahi M,Wu O,et al. Rapid breakdown of microvascular barrier and subsequent hemorrhagic transformation after delayed recombinant tissue plasminogen activator treatment in a rat embolie stroke model[J]. Stroke,2002,33(8) :2100-2104.
  • 2Jian L K,Rosenberg G A. Matrix matalloproteinases and free radicals in cerebral ischemia [J]. Free Radio Biol Med, 2005,39(1) :71-80.
  • 3Gursoy-Ozdemir Y, Can A, Dalkara T, et al. Reperfusioninduced oxidative/nitrative injury to neurovascular unit after focal cerebral ischemia [J]. Stroke, 2004, 35 (6): 1449-1453.
  • 4Montaner J, Fernandez-Cadenas I, Molina CA, et al. Safety profile of tissue plasminogen activator treatment among stroke patients carrying a common polymorphism (C-1562T) in the promoter region of the matrix metalloproteinase-9 gene[J]. Stroke, 2003,34 (12) : 2851-2855.
  • 5刘轲,王明航,李建生,刘振国,刘敬霞.老龄大鼠脑缺血再灌注血脑屏障损伤的变化及意义[J].中风与神经疾病杂志,2005,22(5):413-415. 被引量:8
  • 6Gasche Y,Copin JC. Blood-brain barrier pathophysiology and isehaemic brain edema [J]. Ann Fr Anesth Reanim, 2003,22 (4):312-319.
  • 7Neumann-Haefelin T, Kastrup A, De Crespigny A,et al. Serial MRI after transient focal cerebral iscbemia in rats: dynamics of tissue injury, blood-brain barrier damage, and edema formation[J]. Stroke, 2000, 31( 8): 1965- 1972.
  • 8毛玲,查运红,梅元武.基质金属蛋白酶-9与脑缺血血脑屏障损伤的关系[J].国际神经病学神经外科学杂志,2006,33(1):96-98. 被引量:24
  • 9Lee SR,Lo EH. Induction of caspase-mediated cell death by matrix metalloproteinases in cerebral endothelial cells after hypoxia-reoxygenation [J]. J Cereb Blood Flow Metab,2004,24 (7): 720-727.
  • 10Gidday JM, Gasche Y, Shah AR, et al. Reduction in cerebral vasogenic edema and infarct volum in MMP-9 null mice and following MMP 9 inhibition[J]. Society for Neuroscience Abstracts, 2000,26 ( 1/2) : 286.

二级参考文献30

  • 1申洪.免疫组织化学染色定量方法研究(Ⅲ)[J].中国组织化学与细胞化学杂志,1995,4(1):89-92. 被引量:401
  • 2Mandal M, Mandal A, Das S, et al. Clinical implications of matrix metalloproteinases. Mol Cell Biochem, 2003, 252 ( 1-2 ) :305 -329.
  • 3Malemud CJ. Matrix metalloproteinases (MMPs) in health and disease: an overview. Front Biosci, 2006, 11(1): 1696-1701.
  • 4Castillo J, Leira R, Blanco M. Metalloproteinases and neurovascular injury. Neurologia, 2004, 19 ( 6 ) : 312 -320.
  • 5Hamacher S, Matern S, Roeb E. Extracellular matrix - from basic research to clinical significance. An overview with special consideration of matrix metalloproteinases. Dtsch Meal Wochenschr, 2004, 129(38): 1976-1980.
  • 6Chakraborti S, Mandal M, Das S, et al. Regulation of matrix metalloproleinases: an overview, Mol Cell Biochem, 2003, 253(1-2) : 269-285.
  • 7Hsieh HL, Yen MH, Jou MJ, et al. Intracellular signalings underlying bradykinin-induced matrix metalloproteinase-9 expression in rat brain astrocyte-1. Cell Signal, 2004, 16 ( 10 ) : 1163-1176.
  • 8Chung TW, Lee YC, Kim CH. Hepatitis B viral HBx induces matrix metalloproteinase-9 gene expression through activation of ERK and PI-3K/AKT pathways: involvement of invasive potential. FASEB J, 2004, 18(10): 1123-1125.
  • 9Ruhul Amin AR, Senga T, Oo ML, et al. Secretion of matrix metalloproteinase-9 by the proinflammatory cytokine, IL-1 beta:a role for the dual signalling pathways, Akt and Erk. Genes Cells,2003, 8(6) : 515-523.
  • 10Kato Y, Lambert CA, Colige AC, et al. Acidic extracellular pH induces matrix metalloproteinase-9 expression in mouse metastatic melanoma cells through the phospholipase D-mitogen-activated protein kinase signaling. J Biol Chem, 2005, 280 (12):10938-10944.

共引文献30

同被引文献12

引证文献2

二级引证文献10

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部